| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G/A | Report | SEC SCHEDULE 13G | Sep 9, 2024 | |
| SC 13G/A | Report | JANUS HENDERSON OWNS 10.1% | Jun 10, 2024 | |
| SC 13G | Report | SCHEDULE 13G | Mar 15, 2024 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
| SC 13G | Report | Feb 14, 2024 | ||
| SC 13G/A | Report | SC 13G/A AKERO | Feb 14, 2024 | |
| SC 13G | Report | AKERO THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | Feb 13, 2024 | ||
| SC 13G/A | Report | Feb 13, 2024 | ||
| SC 13G | Report | SCHEDULE 13G | Feb 13, 2024 | |
| SC 13G/A | Report | JHG PLC OWNS >5% | Feb 13, 2024 | |
| SC 13G | Report | SEC SCHEDULE 13G | Feb 8, 2024 | |
| SC 13G/A | Report | AKERO THERAPEUTICS, INC. | Feb 7, 2024 | |
| SC 13G/A | Report | Jan 26, 2024 | ||
| SC 13G/A | Report | Jan 25, 2024 | ||
| SC 13G/A | Report | Sep 12, 2023 | ||
| SC 13G | Report | AKERO THERAPEUTICS, INC. | Apr 10, 2023 | |
| SC 13G/A | Report | AMENDMENT TO FORM SC 13G | Feb 14, 2023 | |
| SC 13G | Report | SC 13G | Feb 14, 2023 | |
| SC 13G/A | Report | SCHEDULE 13G/A, AMENDMENT #2 | Feb 14, 2023 | |
| SC 13G | Report | SC 13G | Feb 14, 2023 | |
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | Feb 13, 2023 | ||
| SC 13G/A | Report | JHG PLC OWNS >5% | Feb 10, 2023 | |
| SC 13G/A | Report | Feb 7, 2023 | ||
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 6, 2023 | |
| SC 13G | Report | Feb 3, 2023 | ||
| SC 13G | Report | Feb 3, 2023 | ||
| SC 13G/A | Report | Dec 5, 2022 | ||
| SC 13G | Report | Nov 9, 2022 | ||
| SC 13G | Report | Sep 16, 2022 | ||
| SC 13G | Report | SC 13G AKERO THERAPEUTICS | Jun 28, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
| SC 13G/A | Report | SCHEDULE 13G (AMENDMENT #1) | Feb 14, 2022 | |
| SC 13G/A | Report | Feb 14, 2022 | ||
| SC 13G/A | Report | AMENDMENT TO SC 13G | Feb 11, 2022 | |
| SC 13G/A | Report | JANUS HENDERSON GROUP PLC OWNS >5% | Feb 10, 2022 | |
| SC 13G | Report | AKERO THERAPEUTICS INC | Feb 8, 2022 | |
| SC 13G | Report | Feb 4, 2022 | ||
| SC 13G | Report | SEC SCHEDULE 13G | Feb 4, 2022 | |
| SC 13G | Report | SCHEDULE 13G | Dec 13, 2021 | |
| SC 13G | Report | Jun 30, 2021 | ||
| SC 13G/A | Report | AMENDMENT TO FORM SC 13G | Feb 16, 2021 | |
| SC 13G | Report | SC 13G | Feb 16, 2021 | |
| SC 13G/A | Report | SC 13G/A | Feb 16, 2021 | |
| SC 13G | Report | Feb 11, 2021 | ||
| SC 13G/A | Report | JANUS HENDERSON GROUP PLC OWNS 10.1% | Feb 11, 2021 | |
| SC 13G/A | Report | SC 13G/A | Feb 5, 2021 | |
| SC 13G/A | Report | JANUS HENDERSON GROUP PLC | Sep 10, 2020 | |
| SC 13G | Report | JANUS HENDERSON GROUP PLC OWNS 8.4% OF AKERO | Feb 14, 2020 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2020 | |
| SC 13G | Report | SC 13G | Feb 13, 2020 | |
| SC 13G | Report | SC 13G | Feb 10, 2020 | |
| SC 13G | Report | SC 13G | Jul 5, 2019 |